Nexalin Technology (NXL) Other Non-Current Assets (2024)
Nexalin Technology (NXL) posted quarterly Other Non-Current Assets of $864.0 for Q4 2024, down 98.41% quarter-over-quarter from $54414.0 in Q2 2024.
Nexalin Technology (NXL) Other Non-Current Assets (2024) Analysis & Trends
Nexalin Technology's Other Non-Current Assets history runs 1 years deep, the most recent figure standing at $864.0 for Q4 2024.
- In Q4 2024, Other Non-Current Assets changed N/A year-over-year to $864.0; the TTM figure through Dec 2024 stood at $864.0 (changed N/A YoY), while the FY2024 annual figure was $864.0, changed N/A from the prior year.
- Other Non-Current Assets for Q4 2024 stood at $864.0, down from $54414.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $54414.0 in Q2 2024, with the low at $864.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 864.00 |
| Jun 30, 2024 | 54,414.00 |